Researchers at Israel’s Technion Institute have discovered unique amyloid fibrils used by the deadly antibiotic resistant MRSA bacteria to attack the immune system. It means treatments that inhibit the amyloid formation will neutralize MRSA.

http://www.technion.ac.il/en/2017/02/staphylococcus-aureus-bacteria/